Global Pancreatic Cancer Therapeutics Market 2019-2023| Expanding Research

Posted by sarahbennu on January 22nd, 2020

The global pancreatic cancer therapeutics market research report forecasts the market to grow at a CAGR of over 8% during the forecast period. The expanding research in immunotherapy will be one of the significant trends in the global pancreatic cancer therapeutics market during 2019-2023. To find the best available therapy that minimizes the chances of cancer relapse, significant research is being undertaken in the global pancreatic cancer therapeutics market. The immunotherapy products such as immune checkpoint inhibitors and vaccines are a part of active research.

pancreatic cancer therapeutics

Looking for more information on this market? Request a free sample report

Global pancreatic cancer therapeutics market: Rising prevalence of pancreatic cancer

The pancreatic cancer is the most common type of gastrointestinal cancer, whose incidence is increasing in developed countries. The high incidence of pancreatic cancer in developed countries is due to the high diagnosis rates and increasing awareness.

According to a research analyst at Technavio, “There are several factors such as tobacco smoking, age, obesity, diabetes, pancreatitis, alcohol consumption, and family history of pancreatic cancer, which contribute to an increase in the risk of pancreatic cancer. Tobacco smoking is a prime risk factor among these factors, as it majorly accounts for the rising incidence of pancreatic cancer globally.”

Global pancreatic cancer therapeutics market: Segmentation analysis

This global pancreatic cancer therapeutics market analysis report provides market segmentation by product (targeted therapy and chemotherapy), by type (exocrine pancreatic cancer and endocrine pancreatic cancer), and by region (the Americas, APAC, and EMEA). This report provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the two major products, the targeted therapy segment held the largest pancreatic cancer therapeutics market share in 2018, contributing to nearly 51% of the market. This product segment will dominate the global market throughout the forecast period.

The Americas held the largest share of the market in 2018, accounting for close to 53% share. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

Like it? Share it!


About the Author

Joined: July 1st, 2019
Articles Posted: 259

More by this author